https://www.youtube.com/embed/qLH7338X2UM?si=2vFVW9aZn5jzSjdH

This is a quick summary of how we invest at Precursor - you can find the full portfolio here if you want to see the companies that we have already backed. More details below on how we invest and what we look for in new investments. If you’d like for us to take a look at your company, please read the information below to make sure it is in spec before submitting our online submission form.

We focus on investing up to $500K in pre-seed and seed rounds of $4 million or less.

• We invest in pre-seed and seed rounds of $4 million or less in companies that are in the early stages of figuring out product-market fit. When we invest, we typically will invest up to $500K.
• We are happy to lead rounds of $1M or less, but we do not need to be the lead investor to participate.
• We look for companies where a $4 million (or less) round will allow the company to answer some of the key questions around the business model, product, or market.
• We don't invest into Series A rounds as an entry point.
• We don't normally invest in rounds that are larger than $4 million in size; we are a small fund, and rounds larger than that typically are out of spec for us.

We invest primarily in companies that are headquartered in North America (USA, Canada, and Mexico).

• We make an exception for fintech companies - we will invest globally in B2B and B2C fintech if we can get comfortable with the market dynamics.

We are a sector-agnostic, generalist firm.

• Our portfolio is a roughly 50/50 split between B2B and B2C companies.
• We typically don't invest in biotech or life science companies; we don't have the scientific background to invest in companies where science is at the core of the innovation.

We have a strict conflict of interest policy for new investments.

• We have a strict conflict policy; we don't invest in companies we think are competitive with our active existing portfolio companies current plans or future aspirations.